Company Overview and News

0
Jobs at fertiliser plant 'saved' by NT gas supply

2018-06-26 abc.net.au
Central Petroleum will supply gas to Incitec Pivot Limited's Gibson Island plant from the end of 2018 for 12 months.
INCZY CTP CPTLY ICPVF IPL

0
Jobs at fertiliser plant 'saved' by NT gas supply

2018-06-26 abc.net.au
Central Petroleum will supply gas to Incitec Pivot Limited's Gibson Island plant from the end of 2018 for 12 months.
INCZY CTP CPTLY ICPVF IPL

1
Global demand for fossil fuels has already peaked

2018-06-04 australianmining.com.au
In 2017, Australia recorded its highest ever annual level of coal exports — valued at $57 billion — making it Australia’s second largest export. Coupled with that, Australia is predicted to be the leading LNG exporter by 2022.
BNT COI CTP COMRF WHC CPTLY

0
LNG exports from Australia to reach $35 billion

2018-05-07 australianmining.com.au
With Australia predicted to be the leading LNG exporter by 2022, growth in the industry has been strong this year.
COI CTP COMRF CPTLY

2
Central Australia onshore gas exploration increases, while minerals slowly recover

2018-03-21 abc.net.au
Santos previously owned the Mereenie oil and gas field west of Alice Springs, before selling to Macquarie Group.
MQBKY CTP MCQEF MQG CPTLY ARAFF ARU

1
Central Petroleum joint-venture to proceed with Mereenie Gas Project under ACCC terms

2018-03-12 proactiveinvestors.com.au
Central Petroleum Limited (ASX:CTP) and its 50:50 joint venture partner Macquarie Group Ltd (ASX:MQG) have taken the decision to develop the Mereenie Gas Project.
MQBKY CTP MQG MCQEF CPTLY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CTP / CENTRAL PETROLEUM LIMITED on message board site Silicon Investor.

ActionPoint, Inc. (ACTP) Steel City Products Inc. (SCTP)
Castle Rock CTP/Vcr Forum -Voisey Bay